Research
Preeti Pandey, PhD
Preeti Pandey, PhD
Dr Preeti Pandey is a highly proficient pharmaceutical product development scientist with over a decades’ experience driving innovative R&D delivery solutions spanning small molecules, biologics, peptides, and protein-based therapeutics. With expertise in the development of topical, intravaginal, nasal local and nose-to-brain drug delivery systems through physician-led engagement. Dr Preeti holds a PhD in Philosophy from the School of Pharmacy from the University of Queensland, where she conducted product development, experimental design and pre-formulation and formulation development within interdisciplinary industry research.
Karnaker Tupally, PhD
Karnaker Tupally, PhD
Dr. Karnaker Tupally is an accomplished Formulation and Bioanalytical Scientist with over 12 years of expertise in drug discovery and development, specializing in novel drug delivery systems, peptide therapeutics, RNA/protein formulations, and nanomaterials for precision medicine. His work spans preclinical to clinical R&D, focusing on Chemistry, Manufacturing, and Controls (CMC), analytical method development, and process optimization to advance next-generation biopharmaceuticals. Dr. Tupally holds a Ph.D. in Pharmaceutical Chemistry from The University of Queensland (UQ), Australia, where he co-invented bio-responsive disulphide-linker technology for non-viral gene delivery and peptide therapeutics targeting pain and cancer treatments.
Rink-Jan Lohman, PhD
Rink-Jan Lohman, PhD
Dr. Rink-Jan Lohman, PhD is a professional pharmaco-toxicologist with 20 years of experience in preclinical drug discovery, specializing in the therapeutic applications of novel test items in animal models of inflammation, pain, and neurological diseases. They are skilled in developing, optimizing, and validating methods for drug testing, and they have extensive experience in GLP, NATA-accredited labs, GCP, and clinical trials and have well over 100 compounds in vivo for efficacy, pharmacokinetics, oral bioavailability, brain delivery, and tissue distribution in various disease models. Dr. Lohman holds a PhD in Neuropharmacology from the University of Melbourne.